In order to provide the pharmacological basis for the usage of Rhodiola rosea L. in the therapy of nervous and cardiovascular diseases in Traditional Chinese Medicine, it was deemed necessary to synthesize these PPGs and evaluate their inhibitory activities towards acetylcholinesterase (AChE) as well as xanthine oxidase (XOD). The gene discussed is ACHE; the disease is cardiovascular disorder.